Active substance
Amiloride
- US FDA 4
- Health Canada 1
- US price lines 1
- NHS prices 2
- WHO EML 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MIDAMOR | 5MG | tablet · oral | PADAGIS US | Prescription | 5 Oct 1981 |
| AMILORIDE HYDROCHLORIDE | 5MG | tablet · oral | PH HEALTH | Prescription | 22 Jan 1986 |
| AMILORIDE HYDROCHLORIDE | 5MG | tablet · oral | SIGMAPHARM LABS LLC | Prescription | 30 Jan 2009 |
| AMILORIDE HYDROCHLORIDE | 5MG | tablet · oral | CHARTWELL RX | Discontinued | 7 Aug 2015 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| MIDAMOR | 02249510 | 5.0 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | AMILORIDE HCL 5 MG TABLET | $0.1901 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Amiloride 5mg tablets | £11.16 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Amiloride 5mg/5ml oral solution sugar free | £158.85 | 150 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 16. Diuretics · core
Oedema; Ascites
Oral > Solid: 5 mg (hydrochloride)
Combinations containing Amiloride
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.